← Scroll for more →
Financial Statements — PTHS
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 24.19 | 31.98 | 17.97 | 14.20 | 0.10 | 0.13 | 0.51 | 1.25 | 2.41 | 3.80 | 0.10 |
| Accounts Receivable | 14.48 | 11.70 | 8.86 | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | 21.47 | 23.42 | 23.57 | 24.10 | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 63.36 | 69.80 | 53.41 | 49.76 | 0.82 | 0.91 | 1.37 | 2.14 | 2.60 | 4.03 | 0.10 |
| Property, Plant & Equipment | 8.88 | 9.31 | 9.59 | 10.17 | -- | -- | -- | -- | -- | -- | -- |
| Goodwill | 24.68 | 24.68 | 24.68 | 30.63 | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | 37.40 | 38.44 | 39.47 | 32.52 | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 74.00 | 75.58 | 76.99 | 76.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 137.36 | 145.38 | 130.40 | 126.43 | 0.82 | 0.91 | 1.37 | 2.14 | 2.60 | 4.03 | 0.10 |
| Accounts Payable | 5.85 | 6.15 | 2.99 | 5.67 | 4.99 | 2.60 | 1.90 | 1.28 | 0.84 | 2.41 | 4.62 |
| Total Current Liabilities | 31.96 | 25.00 | 25.99 | 24.77 | 7.32 | 5.11 | 4.08 | 3.57 | 2.79 | 2.90 | 6.54 |
| Total Non-current Liabilities* | 106.90 | 101.11 | 65.52 | 43.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 138.86 | 126.11 | 91.52 | 68.18 | 7.32 | 5.11 | 4.08 | 3.57 | 2.79 | 2.90 | 6.54 |
| Retained Earnings | (113.28) | (89.87) | (64.79) | (43.13) | (26.89) | (23.44) | (21.47) | (19.55) | (17.85) | (16.08) | (13.52) |
| Total Stockholder Equity | (1.50) | 19.27 | 38.88 | 58.25 | (6.49) | (4.20) | (2.71) | (1.43) | (0.18) | 1.13 | (6.44) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15.60 | 10.91 | 16.50 | 0.29 | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | 3.61 | 1.67 | 1.67 | 2.32 | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | 11.99 | 9.23 | 7.72 | 5.09 | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | 0.60 | 0.19 | 0.37 | 0.14 | 0.51 | 0.19 | 0.29 | 0.41 | 0.01 | 0.47 | 2.29 |
| Selling, General & Admin | 27.67 | 21.10 | 18.47 | 19.63 | 1.11 | 1.09 | 0.95 | 1.16 | 1.21 | 0.79 | 1.06 |
| Total Operating Expenses | 29.32 | 22.32 | 17.40 | 22.77 | 3.23 | 1.83 | 1.83 | 2.05 | 1.76 | 1.93 | 3.88 |
| Operating Income | (17.32) | (13.09) | (12.00) | (15.36) | (3.23) | (1.83) | (1.83) | (2.05) | (1.76) | (1.93) | (3.88) |
| Interest Expense | -- | -- | -- | 1.35 | -- | 0.00 | -- | -- | -- | -- | -- |
| Pretax Income | (23.42) | (25.07) | (28.59) | (16.70) | (3.45) | (1.97) | -- | (1.69) | (1.77) | (2.56) | (4.04) |
| Tax Provision | 0.00 | 0.00 | (6.92) | (0.46) | -- | -- | -- | -- | -- | -- | -- |
| Net Income | (23.42) | (25.07) | (21.66) | (16.24) | (3.45) | (1.97) | (1.93) | (1.69) | (1.77) | (2.56) | (4.04) |
| Basic EPS | (6.62) | (7.57) | (12.04) | (5.30) | (5.38) | (0.32) | (0.28) | (0.29) | (0.31) | (0.55) | 9.04 |
| Diluted EPS | (6.62) | (7.57) | (12.04) | (5.30) | (5.38) | (0.32) | 5.12 | -- | -- | -- | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (7.66) | (13.13) | (6.25) | (15.26) | (0.45) | (0.63) | (0.67) | (0.18) | (2.95) | (1.99) |
| Capital Expenditures | 0.00 | 0.19 | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow* | (7.67) | (13.32) | -- | -- | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | -0.00 | (0.19) | (8.00) | 2.76 | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | 0.00 | 27.52 | 18.02 | 26.69 | 0.38 | 0.25 | (0.07) | (0.97) | 1.59 | 5.67 |
← Scroll for more columns →
* Derived from reported values